← IPO Calendar

Sudarshan Pharma Industries IPO IPO

Mainline9 Mar 202314 Mar 2023
Open
9 Mar 2023
Close
14 Mar 2023
3
Allotment
Listing
Wed, Mar 22, 2023
Price Band
₹71 to ₹73
Issue Size
68,62,400 shares (agg. up to ₹50 Cr)
Lot Size
1,600 Shares
Listing Date
Wed, Mar 22, 2023
Latest GMP
₹5
Est. Gain
6.85%
✦ AI Insight

GMP Trend

22-03-20235Est. ₹78+6.85%
21-03-20235Est. ₹78+6.85%
20-03-20238Est. ₹81+10.96%

Live Subscription

CategorySubscription (times)
Total1.01x

Restated Financials (₹ Cr.)

Period Ended30 Sep 202231 Mar 202231 Mar 2021
Assets164.02137.5299.26
Total Income195.90357.56193.73
Profit After Tax3.615.302.67
NET Worth51.0929.7822.51
Reserves and Surplus39.9720.0312.96
Total Borrowing49.4130.5929.77
Amount in ₹ Crore

Peer Comparison

CompanyIssue TypeIssue SizeIssue PricePE RatioListing Day CloseListing Gain/Loss %LTP
Rite Zone Chemcon India Ltd.SME₹8.96 Cr₹7590.36₹86.95+15.93%₹22.65 (-4.83%)
Vital Chemtech Ltd.SME₹64.64 Cr₹10114.94₹163.10+61.49%₹50.77 (-1.99%)
Bhatia Colour Chem Ltd.SME₹40.00 Cr₹80166₹42.00-47.50%₹41.12 (-3.06%)
Archean Chemical Industries Ltd.Mainboard₹1,462.30 Cr₹40716.78₹458.15+12.57%₹550.40 (+0.00%)
Aether Industries Ltd.Mainboard₹808.04 Cr₹64272.3₹774.40+20.62%₹1,475.30 (-1.42%)

Objects of the Issue

#Issue ObjectsEst Amt (₹ Cr.)
1To set up a dedicated manufacturing facility for Pharmaceutical Business12.50
2Distribution and Warehousing Centre‘s & Purchase of Corporate Office4.50
3Additional Working Capital5.25
4General Corporate Expenses2.80

About Sudarshan Pharma Industries IPO

Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad. The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions. The competitive strengths of the company are:1. Customer

Contact Details

Sudarshan Pharma Industries Ltd. Address301, 3rd Floor, Aura BiplexAbove Kalyan Jewellers S.V.Road, Borivali (West)Mumbai, Maharashtra, 400092022- 42221111compliance@sudarshanpharma.comVisit Website